Sanofi Ventures — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Click Therapeutics develops software-based prescription medical treatments for patients with unmet medical needs, combining neuroscience with digital technology to create a new treatment modality.
Digital HealthHealthtechMedical DevicesNew York, US
David B. Klein(Founder and CEO)Randall Stanicky(Executive Officer)Nicholas Schork(Director)Victor Gao(Director)Emile Westergaard(Director)
BoardAlex Zisson(Director)
Board seatCris De Luca· per SEC Form D
Genetix Biotherapeutics (formerly bluebird bio) develops gene therapies for patients with rare genetic diseases including sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy.
BiotechLongevityMedical Devices
David Meek(Chief Executive Officer)Brian Riley(President & Chief Technical Officer)Joanne Lager(Chief Medical Officer)Wendy DiCicco(Chief Financial Officer)Adrian Chaisson(Chief of Staff)Daniel S. Lynch(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.